Viromax Life Sciences Llp - Company Profile

It is a pharma limited liability partnership based in Hyderabad, Telangana, India, established in 2020.
2020 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Viromax Life Sciences Llp

Viromax Life Sciences Llp, a active limited liability partnership, was established on 03 November 2020 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the pharma sector, it holds LLPIN: AAU-5268. Registered under ROC Roc Hyderabad. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Talluri Venkata Ramanuja Vijay Kumar (Designated Partner), Madhura Rekha Chinnaboina (Designated Partner). Past directors included Ghanta Azad Babu, Padmavathi Sri Krishna Veerapaneni. Its latest date of accounts and solvency statement 31 March 2022. It is based at 9-4-84/2, Kakatiya Nagar, Hyderabad, Telangana, 500008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAU-5268

  • Incorporation Date

    03 November 2020

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2022
Company report

Viromax Life Sciences Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Viromax Life Sciences Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Viromax Life Sciences Llp?
Current Designated Partners
Name Designation Appointment Date Status
Talluri Venkata Ramanuja Vijay Kumar Designated Partner 03 Nov 2020 Current
Madhura Rekha Chinnaboina Designated Partner 22 Mar 2021 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Partner 22 Mar 2021 Past
Pramod Abcsdd Designated Partner 22 Mar 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Viromax Life Sciences Llp.

Enhance accessibility to Viromax Life Sciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Viromax Life Sciences Llp revenue growth over time
Viromax Life Sciences Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Viromax Life Sciences Llp?

Unlock access to Viromax Life Sciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Viromax Life Sciences Llp?

Unlock and access historical data on people associated with Viromax Life Sciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Viromax Life Sciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viromax Life Sciences Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Viromax Life Sciences Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Viromax Life Sciences Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Viromax Life Sciences Llp has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    Progress on Madhura Rekha Chinnaboina was appointed as a Designated Partner was appointed as a Designated Partner on 22 Mar 2021 & has been associated with this company since 4 years 11 months . was documented.

  • Director Appointment

    Talluri Venkata Ramanuja Vijay Kumar was appointed as a Designated Partner was appointed as a Designated Partner on 03 Nov 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on Viromax Life Sciences Llp was registered on 03 Nov 2020 with Roc Hyderabad & aged 5 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Viromax Life Sciences Llp?

The LLPIN of Viromax Life Sciences Llp is AAU-5268.

Where is Viromax Life Sciences Llp headquartered?

Viromax Life Sciences Llp is headquartered at 9-4-84/2, Kakatiya Nagar, Hyderabad, Telangana, 500008.

When was Viromax Life Sciences Llp incorporated?

Viromax Life Sciences Llp was incorporated on 03 November 2020.

Who are the current directors of Viromax Life Sciences Llp?

The current directors of Viromax Life Sciences Llp are

What is the primary industry of Viromax Life Sciences Llp?

The primary industry of Viromax Life Sciences Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available